Pyridine derivatives are a family of heterocyclic nitrogenous compounds possessing many of applications in the discovery of anticancer drug. This synthetic category serve as the potent class of compounds in the treatment of many types of tumors as breast cancer, myeloid leukemia, pancreatic cancer, liver cancer. In this review, the recent results of the published studies about pyridine derivatives were reported. In addition, the most promising candidates in each work was focused mentioning it anticancer activity compared to the reference molecules. This work may serve as a collection of promising candidates for further design and synthesis of anti-cancer agents.
El-Zahabi, M. A., Yousef, R., Eissa, I., & Elwan, A. (2023). PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS. Al-Azhar Journal of Pharmaceutical Sciences, 68(2), 64-81. doi: 10.21608/ajps.2023.332167
MLA
Mohamed Ayman ALy El-Zahabi; Reda G Yousef; Ibrahim H Eissa; Alaa Elwan. "PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS", Al-Azhar Journal of Pharmaceutical Sciences, 68, 2, 2023, 64-81. doi: 10.21608/ajps.2023.332167
HARVARD
El-Zahabi, M. A., Yousef, R., Eissa, I., Elwan, A. (2023). 'PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS', Al-Azhar Journal of Pharmaceutical Sciences, 68(2), pp. 64-81. doi: 10.21608/ajps.2023.332167
VANCOUVER
El-Zahabi, M. A., Yousef, R., Eissa, I., Elwan, A. PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS. Al-Azhar Journal of Pharmaceutical Sciences, 2023; 68(2): 64-81. doi: 10.21608/ajps.2023.332167
)
View on SCiNiTO